20250174318. Digital Medicine Companion Cdk (PFIZER .)
DIGITAL MEDICINE COMPANION FOR CDK INHIBITOR MEDICATIONS FOR CANCER PATIENTS
Abstract: the present disclosure relates to a digital medicine companion for patients undergoing oncology treatments. a patient may enter symptoms on a prescription software. a wearable device may passively collect other healthcare data such as biological data and/or physical activity data. the patient may therefore be monitored using the prescription software and/or wearables. furthermore, the prescription software may be integrated with biofluid testing systems. for example, an at-home biofluid monitoring kit and/or a laboratory system may communicate with the prescription software and/or its backend server. the healthcare data collected through the monitoring and the biofluid testing may be fed into a machine learning model, which may output whether the patient is likely to develop side effects such as cytopenia. one or more alert notifications, e.g., to a clinician dashboard and/or to the prescription software, may be triggered when the machine learning model determines a higher likelihood of such side effects.
Inventor(s): Anthony LAMBROU, Ofer WAKS, Caroline J. HOANG, Xuemei CAI, Ahsan HUDA, Timothy DOUGHERTY, Dennis P. HANCOCK, Joshua RAYSMAN, Solomon RAVICH
CPC Classification: G16H10/40 (for data related to laboratory analysis, e.g. patient specimen analysis)
Search for rejections for patent application number 20250174318
- Patent Applications
- PFIZER INC.
- CPC G16H10/40
- Anthony LAMBROU of New York NY US
- Ofer WAKS of New York NY US
- Caroline J. HOANG of Peapack NJ US
- Xuemei CAI of Cambridge MA US
- Ahsan HUDA of New York NY US
- Timothy DOUGHERTY of Collegeville PA US
- Dennis P. HANCOCK of Collegeville PA US
- Joshua RAYSMAN of San Diego CA US
- Solomon RAVICH of New York NY US